Throughout this medical market research, the publisher analyzed 43 interventional cardiology device companies in the US and utilized their comprehensive methodology to understand the Market Sizes, Unit Sales, ASPs, Company Market Shares, and to create accurate forecasts.
While this MedSuite report contains all of the US Interventional Cardiology Device market analysis, each of the market segments is also available as stand-alone MedCore reports. Additionally, this research includes an interventional cardiology procedure volume analysis which can also be purchased as a separate report, MedPro.
Markets Covered
US Interventional Cardiology Device Market Insights
Similar to other medical device markets, the interventional cardiology market has been experiencing a period of consolidation in recent years. Large competitors are either entering the overall market or expanding their reach by entering new segments through strategic mergers and acquisitions. A recent survey shows that one-quarter of healthcare professionals believe that healthcare industry consolidation was the most important trend in 2019.
Similar to other medical device markets, the interventional cardiology market has been experiencing a period of consolidation in recent years. Large competitors are either entering the overall market or expanding their reach by entering new segments through strategic mergers and acquisitions. A recent survey shows that one-quarter of healthcare professionals believe that healthcare industry consolidation was the most important trend in 2019.
Overall, the U.S. interventional cardiology device market was valued at approximately $3.2 billion in 2019. This is expected to increase to $4.1 billion by 2026, resulting in a CAGR of 3.6%.
While this MedSuite report contains all of the US Interventional Cardiology Device market analysis, each of the market segments is also available as stand-alone MedCore reports. Additionally, this research includes an interventional cardiology procedure volume analysis which can also be purchased as a separate report, MedPro.
Markets Covered
- Procedure Volumes for the US Interventional Cardiology Market - MedPro
- Coronary Stent Market - MedCore
- Coronary Balloon Catheter Market - MedCore
- Introducer Sheath Market - MedCore
- Balloon-Inflation Device Market - MedCore
- Interventional Coronary Catheter Market- MedCore
- Interventional Coronary Guidewire Market - MedCore
- Coronary Embolic Protection Device Market - MedCore
- Coronary Atherectomy Device Market - MedCore
- Coronary Thrombectomy Market - MedCore
- Coronary Chronic Total Occlusion (CTO) System Market - MedCore
- Coronary Vascular Closure Device (VCD) Market - MedCore
- Diagnostic Coronary Catheter & Guidewire Market - MedCore
- Coronary Intravascular Ultrasound (IVUS) Market - MedCore
- Coronary Optical Coherency Tomography Market - MedCore
- Hemostasis Valve Market - MedCore
US Interventional Cardiology Device Market Insights
Similar to other medical device markets, the interventional cardiology market has been experiencing a period of consolidation in recent years. Large competitors are either entering the overall market or expanding their reach by entering new segments through strategic mergers and acquisitions. A recent survey shows that one-quarter of healthcare professionals believe that healthcare industry consolidation was the most important trend in 2019.
Similar to other medical device markets, the interventional cardiology market has been experiencing a period of consolidation in recent years. Large competitors are either entering the overall market or expanding their reach by entering new segments through strategic mergers and acquisitions. A recent survey shows that one-quarter of healthcare professionals believe that healthcare industry consolidation was the most important trend in 2019.
Overall, the U.S. interventional cardiology device market was valued at approximately $3.2 billion in 2019. This is expected to increase to $4.1 billion by 2026, resulting in a CAGR of 3.6%.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Abbott
- ACIST
- Acrostak
- Advanced Vascular Dynamics
- AngioDynamics
- Argon Medical
- Asahi Intecc
- B. Braun
- Baylis Medical
- Becton Dickinson
- Biolife
- Biotronik
- Boston Scientific
- Cardinal Health
- Cardiovascular Systems Inc.
- Cardiva Medical
- CeloNova
- Control Medical Technology
- Cook Medical
- Galt Medical
- Getinge
- ICU Medical
- Infraredx
- InnoTherapy
- Medtronic
- Merit Medical Systems
- Morris Innovative
- Opsens Medical
- Oscor
- PediaVascular
- Penumbra
- Philips
- Reflow Medical
- Rontis
- Semier Technologies
- Teleflex
- Terumo
- Tricol Biomedical
- Tryton Medical
- TZ Medical
- US Endoscvascular
- Vivasure
- Z-Medica
